| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 193.191 | 211.346 | 192.625 | 0 | 90.382 | 0 | 0 |
| Total Income - EUR | 4.760 | 2.343 | 1.576 | 193.872 | 232.904 | 199.956 | 5.962 | 101.033 | 25.091 | 426 |
| Total Expenses - EUR | 6.828 | 12.040 | 1.150 | 1.356 | 53.536 | 42.659 | 32.585 | 20.509 | 37.046 | 11.951 |
| Gross Profit/Loss - EUR | -2.068 | -9.698 | 426 | 192.516 | 179.368 | 157.297 | -26.623 | 80.524 | -11.955 | -11.525 |
| Net Profit/Loss - EUR | -2.083 | -9.704 | 408 | 190.583 | 177.255 | 155.371 | -26.623 | 79.620 | -11.955 | -11.525 |
| Employees | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Mabusmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.654 | 41 | 40 | 39 | 1.841.228 | 1.806.323 | 1.766.266 | 1.771.746 | 1.766.373 | 1.756.501 |
| Current Assets | 90.698 | 90.343 | 55.728 | 208.326 | 231.249 | 247.685 | 77.494 | 81.214 | 85.037 | 48.529 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Receivables | 90.845 | 90.247 | 25.439 | 198.292 | 105.833 | 243.704 | 66.697 | 67.064 | 67.096 | 28.391 |
| Cash | -147 | 96 | 30.289 | 10.034 | 125.416 | 3.980 | 10.797 | 14.150 | 17.940 | 20.137 |
| Shareholders Funds | 60.258 | 85 | 492 | 191.065 | 364.704 | 513.161 | 475.159 | 556.253 | 542.611 | 528.053 |
| Social Capital | 225 | 223 | 219 | 215 | 295 | 289 | 283 | 284 | 283 | 281 |
| Debts | 40.094 | 90.298 | 55.276 | 17.300 | 1.707.772 | 1.540.846 | 1.368.600 | 1.296.706 | 1.308.799 | 1.276.977 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4110 - 4110" | |||||||||
| CAEN Financial Year |
4110
|
|||||||||
Comments - Mabusmed S.r.l.